Sunday, May 24, 2009

How Much for Access to APA Mtg Talks?

The American Psychiatric Association's 162nd Annual Meeting just ended in San Francisco last week.  These are 5-day long academic smorgasborgs attended by a large proportion of the APA's 35,000-plus members, in addition to other interested people. 

There were about 600 individual talks totaling about 600 hours, not to mention the 800-odd poster presentations.  To see an example of the first two days' worth of talks, skip to the bottom of this post.  

We are thinking about bringing most of the meetings' talks online -- audio, video, slides, and all.  Here's my question: Do these talks have any interest outside of just psychiatrists?  How much would you be willing to pay on a per-talk basis (this is the non-member price)?  These would be streaming talks (not downloads) and payment includes access for 12 months so it can be watched multiple times (update: no CME).

(Please tweet this survey, blog it, email it, circulate widely. Thanks.)

View Comments

Below is a list of talks from the first couple days.

Advances in Medicine (~1.5 each) 

AM01. The Top 10 Medical Articles of 2008: A Comprehensive and Practical Review of What We Need to Know Monique Yohanan, M.D. 

AM02. Infertility Issues Elena Gates, M.D. 

Advances In Research (~3 hr each) 

AR01. Advances in Research. Herbert Pardes, M.D. 

Advances In Series (~3 hr each) 

A01. Neuropsychiatry Stuart Yudofsky, M.D. 

A02. Psychopharmacology Alan Schatzberg, M.D., Charles Nemeroff, M.D. 

A03. Substance Abuse Mark Galanter, M.D., Herbert Kleber, M.D. 

A04. Psychosomatic Medicine James L. Levenson, M.D. 

A05. Psychotherapuedic Psychiatry Glen Gabbard, M.D. 

A06. Personality Disorder John Oldham, M.D. 

A07. Forensic Psychiatry Robert I. Simon, M.D., Lisa Gold, M.D. 

Component Workshops (~1.5 hr each) 

CW01. High-Risk Student Populations: Innovative Approaches to Treatment and Outreach. Chair: Jerald Kay, M.D. 

CW02. Lost and Not Found: Depression and Suicide in Elderly Asian Americans. APA Committee of Asian-American Psychiatrists; Chair: Jacquelyn Chang, M.D. 

CW03. A Family-Related Approach to Reducing Risk and Promoting Well-Being Among LGBT Youth. Association of Gay and Lesbian Psychiatrists; Chair: Ellen Haller, M.D. 

CW04. International Disasters: Challenges and Opportunities to Contribute. APA Committee on Psychiatric Dimensions of Disaster; Chair: Shirley Liu, M.D., Co-Chair: Patcho Santiago, M.D. 

CW05. Career Advancement in Administrative Psychiatry for Early Career Psychiatrists. APA Assembly Committee of Early Career Psychiatrists; Chair: Dimitri Markov, M.D., Co-Chair: Marina Goldman, M.D. 

CW06. Show Me the Money! Sustainable Funding for Education in Psychiatry. APA/GlaxoSmithKline Fellows; Chair: M. Justin Coffey, M.D. 

CW07. Revitalizing Service: Strategic Planning Success Within District Branches and State Associations APA Council on Member and District Branch Relations; Chair: Nioaka Campbell, M.D. 

CW08. Combat to Community: Needs and Resources for Post-September 11th Veterans and Their Families APA Alliance; Chair: Kay Brada 

CW09. Becoming a Public Psychiatry Leader: Mentoring Models for Everyone, From Residents to Medical Directors APA Council on Social Issues and Public Psychiatry; Chair: Peter Chien, M.D. 

CW10. Biracial Americans: "Check One Box Only" and the Development of Multiracial Identity APA Council on Minority Mental Health and Health Disparities; Chair: Jacquelyn Chang, M.D., Co-Chair: Kehinde Ogundipe, M.D. 

CW11. Recognition and Treatment of Dementia in a Changing America APA Committee on Ethnic Minority Elderly; Chair: Maria llorente, M.D., Co-Chair: Khushro Unwalla, M.D. 

CW12. How General Psychiatrists Can Effectively Screen and Treat Substance Use Disoders APA Corresponding Committee on Treatment Services for Patients With Addictive Disorders; Chair: Varinder Rathore, M.D., Co-Chair: Petros Levounis, M.D. 

CW13. Outpatient Forensic Services and Interventions to Improve Clinical Outcomes and Reduce Recidivism APA Task Force on Forensic Outpatient Services; Chair: Steven Hoge, M.D., Co-Chair: Alec Buchanan, Ph.D. 

CW14. National Security, the Hippocratic Oath, and the War on Terror APA Council on Global Psychiatry; Chair: Shirin Ali, M.D., Co-Chair: Karinn Glover, M.D. 

CW15. Current Topics in Forensic Psychiatry: Update From the Council on Psychiatry and Law and the Committee on Judicial Action APA Council on Psychiatry and Law and APA Committee on Judicial Action; Chair: Patricia Recupero, M.D., J.D., Co-Chair: Jeffrey Janofsky, M.D. 

CW16. Indications for the Use of Combined Talking Therapy and Pharmacotherapy and How to Teach in Residency APA Corresponding Committee on Graduate Education; Chair: Sidney Weissman, M.D. 

CW17. Medical Issues for Psychiatrists in Disasters APA Committee on Psychiatric Dimensions of Disaster; Chair: Mark Viron, M.D., Co-Chair: Nidal Hasan, M.D. 

CW18. Ethical Dilemmas in Psychiatric Practice APA Ethics Committee; Chair: Wade Myers, M.D. 

Debate/Roundtable (~1.5 hr each)

DR01. To Be Announced 

DR02. To Be Announced 

DSM Track (~3 hr each) 

DSM01. DSM-V: Progress in Research and Development Chair: Darrel Regier, M.D. (Forum 01) 

DSM02. Evolution of the DSM-V Conceptual Framework: Development, Dimensions, Disability, Spectra, and Gender/Culture Chair: Darrell Regier, M.D. 

DSM04. Public Health—Revisions Review Chair: Norman Sartorius, M.D. 

Focus Live (~1.5 hr each) 

FL01. FOCUS LIVE! Geriatric Psychiatry. Barry Lebowitz, Ph.D. 

FL02. FOCUS LIVE! PTSD and Disaster Psychiatry Anand Pandya, M.D. 

FL03. FOCUS LIVE! Panic and Social Anxiety Disorder Mark Pollack, M.D. 

Forum (~1.5 hr each) 

F01. DSM-V: Progress in Research and Development Chair: Darrel Regier, M.D. (DSM Track 01) 

F02. The Relationship Between the APA and Pharmaceutical Industry Chair: Ken Silks, M.D. 

F03. Developing the Next Generation of Clinical Translational Researchers: Innovation in an Academic Department of Psychiatry Chair: Renée Binder, M.D. 

F04. Treating Women With Alcohol Use Disorders Chair: Grace Chang, M.D. 

F05. Anxiety in Patients With HIV: Importance and Drugs Chair: Ramaswany Viswanathan, M.D. 

F06. Bridges and Barriers to Care: Current Strategies Chair: Mark Townsend, M.D. 

F07. New Perspectives on Cultural Issues in Alcohol Chair: Barbara McCrady, M.D. 

Issue Workshops (~1.5 hr each) 

IW01. Increasing Cultural Competency to Assess and Ameliorate Distress of Diverse Patients: Example From the Care of a South Asian Victim of Spousal Abuse. Chair: Jacob Sperber, M.D., Co-Chair: Nyapati Rao, M.D. 

IW02. Practical Pharmacotherapy for the Treatment of Alcohol Dependence National Institute on Alcohol Abuse and Alcoholism; Chair: Robert Swift, M.D., Co-Chair: Allen Zweben 

IW03. Incest—a Cultural Perspective APA Council on Global Psychiatry and the APA Council on Children, Adolescents, and Their Families; Chair: Rodrigo A. Muñoz, M.D. 

IW04. Playing in the Big League: Resident Leadership in the APA Board of Trustees Chair: Molly McVoy, M.D., Co-Chair: Lauren Sitzer, M.D. 

IW05. Risk Management Issues in Psychiatric Practice Chair: Martin Tracy, J.D., Co-Chair: Jacqueline Melonas, J.D. 

IW06. Ethical, Clinical, and Legal Challenges Chair: Malkah Notman, M.D., Co-Chair: Linda Jorgenson, J.D. 

IW07. Technology and Psychiatry: Practical and Clinical Tips for Using Telepsychiatry (Open to residents only) APA/Shire Fellowship Program; Chair: Jena Worley, M.D., Co-Chair: Michael Houston, M.D. 

IW08. Mindful Practice: Understanding Its Role in Psychiatry and Psychiatric Training Chair: Tana Grady-Weliky, M.D. 

IW09. Need to Reformulate "Risk" and Its "Assessment" in Clinical Practice World Psychiatric Association; Chair: Amresh K. Shrivastava, M.D. 

IW10. Imaging Insight: Basic Definitions, Measures, and Relevance to Psychopathology National Institute on Drug Abuse; Chair: Steven Grant, Ph.D., Co-Chair: Rita Goldstein 

IW11. Implementing a Telepsychiatry Program in the Kern County Mental Health System in Rural California (Part 2) Chair: Salvador del Rosario, M.D., Co-Chair: Tai Yoo, M.D. 

IW12. Using the DSM-IV-TR Cultural Formulation for Cultural Competence Skill Building Among Psychiatry Residents Chair: Treniece Lewis Harris, Ph.D., Co-Chair: Marshall Forstein, M.D. 

IW13. Diversion of Prescription Stimulants National Institute on Drug Abuse; Chair: Moira O'Brien, Co-Chair: Wilson Compton III, M.D. 

IW14. Challenging Stigmas & Stereotypes: Integrated Therapy for Multidiagnosed Addiction Patients Combining Innovative With Traditional Approaches Chair: Michael Scimeca, M.D. 

IW15. Man- and Non-Man-Made Disasters in Asia: The Role of Resilience Chair: Pedro Ruiz, M.D. 

IW16. Turning Lead Into Gold: Tragedy and Transformation in a Public Psychiatric Emergency Service Chair: Stephen M. Goldfinger, M.D., Co-Chair: Ellen Berkowitz, M.D. 

IW17. Can Disclosure of a Diagnosis of Borderline Personality Disorder Help Guide Treatment for Clinicians, Patients, and Families? Chair: Richard G. Hersh, M.D. 

IW18. Application of Cultural Variables for Practice of Effective Psychotherapy of Indians Settled in U.S.A. Chair: Nitin Gupta, M.D., Co-Chair: Vijoy Varma, M.D. 

IW19. Cognitive Therapy for Psychosis in Practice by Psychiatrists: Basic Techniques Chair: Shanaya Rathod, M.D., Co-Chair: Douglas Turkington 

IW20. Resident Wellness Survey Results and Discussion Chair: Paul O'Leary, M.D., Co-Chair: Hind Benjelloun, M.D. 

IW21. Tips for Effective Communication About Genetics and Mental Illness With Patients and Their Families Chair: Jehannine Austin, Ph.D., Co-Chair: Holly Peay, M.S. 

IW22. Clinical and Forensic Issues Concerning Infanticide, the Murder of a Child in the First Year of Life by Its Mother Chair: Malkah Notman, M.D., Co-Chair: Carl Malmquist, M.D. 

IW23. Extended Treatments for Alcohol Use Disorders National Institute on Alcohol Abuse and Alcoholism; Chair: James McKay, Ph.D. 

IW24. Cognitive Therapy for Personality Disorders Chair: Judith Beck, Ph.D. 

IW25. The Impact of Meditation as a Non-Pharmacological Intervention for Veterans With Mental Health Disorders Chair: Julie Malphurs, Ph.D., Co-Chair: Daniella David, M.D. 

IW26. Assessment of Capacity: Developments, Documentation, and Defendability Chair: Michael Wise, M.B.B.S., Co-Chair: Julian Beezhold, M.D. 

IW27. Lessons Learned About Resilience and Recovery Following Disasters Chair: Howard Osofsky, M.D. 

IW28. When Psychiatry Residents Treat Medical Students: Some Challenges Chair: Michael Myers, M.D. 

IW29. Bootcamp for Burnout Association of Women Psychiatrists; Chair: Tana Grady-Weliky, M.D. 

IW30. Lessons From the Post-Residency Road: Four Career Journeys Since Residency Graduation 

in 2004, With Insights From Our Training Director Chair: William Wood, M.D., Co-Chair: Kathy Sanders, M.D.

IW31. Assessment and Treatment of Sleep Disorders in Alcohol-Dependent Patients With ADHD and Other Co-Occurring Disorders National Institute on Alcohol Abuse and Alcoholism; Chair: Kirk Brower, M.D., Co-Chair: Iyad Alkhouri, M.D. 

IW32. Doing it Right the First Time: Recognizing, Maintaining, and Supporting Workplace Function APA Corresponding Committee on Psychiatry in the Workplace; Chair: Andrea Stolar, M.D. 

IW33. The Use of Research Measures in Clinical Practice Chair: Joan Busner, Ph.D. 

IW34. FFT-HPI and FIT: Two Different Approaches to Family-Involved Treatment for Bipolar Disorder Chair: Igor Galynker, M.D. 

IW35. Outpatient Mastectomies: Overview of Psychosocial Issues Chair: Zach Morairty, M.D., Co-Chair: Michelle Riba, M.D. 

IW36. Evaluation and Management of Patients With Excessive Daytime Sleepiness in Psychiatric Practice Chair: Dimitri Markov, M.D. 

IW37. The Portrayal of Psychiatry in Recent American Film Chair: Steven Pflanz, M.D. 

IW38. The Changing Managed Care Landscape for Behavioral Health Services National Institute on Alcohol Abuse and Alcoholism; Chair: Constance Horgan Sc.D., Co-Chair: Mark Willenbring, M.D. 

Lectures (~1.5 hr each)

L01. Prevalence, Correlates, and Risk of Posttraumatic Stress Disorder: How Latinos Fare.  Margarita Alegria, Ph.D., Simon Bolivar Award Lecture 

L02. Psychopathic Disorders Without Borders.  Alan R. Felthous, M.D., Henning Sass, M.D., AAPL/APA's Manfred S. Guttmacher Award Lecture 

L03. Pills to Treat Alcoholism. Bankole A. Johnson, M.D., Ph.D., D.S., Solomon Carter Fuller Award Lecture 

L04. Psychiatrists' Role in Prevention and Intervention in Domestic Violence Among South Asians. Surinder Sucha Nand, M.D., Alexandra Symonds Award Lecture

L05. Psychiatric Genetics: A Current Perspective. Kenneth Kendler, M.D., Distinguished Psychiatrist Lecture 

L06. Etiology in Psychiatry: Phenomes, Genomes, and Epigenomes. James Potash, M.D., Frontiers of Science Lecture 

L07. Psychiatric Education Across Civilization: The Search for a Guru and the IMG Nypati Rao, M.D., George Tarjan Award Lecture 

L08. Mental Health in the New Era of Cost Control Richard Frank, M.D., Frontiers of Science Lecture 

L09. To Be Announced Elyn Saks, J.D., Outside Lecture 

L10. Successful Aging and Wisdom: Are These for Real? Dillip Jeste, M.D., Distinguished Psychiatrist Lecture 

L12. To Be Announced Hon. Gavin Newsom, John Fryer Award 

L13. Modules of the Mind: Developing a Positive Psychiatry of the Person C. Robert Cloninger, M.D., Marmor Award Lecture 

L14. Borderline Personality Disorder: The Birth Pains of the Still New Diagnosis John Gunderson, M.D., Distinguished Psychiatrist Lecture 

L15. Cross-Cultural Psychopharmacology: Shaping Our Future via Bridging Science and Service Edward Pi, M.D., Kun-Po Soo Award Lecture 

L16. How Alcoholism Develops: Identification of Genetic and Environmental Influences in a 25-Year Longitudinal Study Marc Shuckit, M.D., Adolf Meyer Award Lecture 

L17. When Politics Distorts Science: A Psychiatrist Reports From the Trenches of the Culture Wars Jack Drescher, M.D., Distinguished Psychiatrist Lecture 

L18. The Movement for Global Mental Health: Why You Should Join Virkram Patel, M.Sc., M.R.C.Psych., Ph.D., International Lecture 

L19. Translational Neuroscience for Schizophrenia Akira Sawa, M.D., Ph.D., Frontiers of Science Lecture 

Media Workshop (~3 hr each) 

MW1. Ready? OK! A Film About Childhood Gender Variance American Academy of Child and Adolescent Psychiatry; Chair: Richard Pleak, M.D., Co-Chair: Sarah Herbert, M.D. 

MW2. Silver Spurs—Severe and Chronic Mental Illness, and Life in a Residential Care Facility Chair: Steven Harvey, M.D., Co-Chair: Doug Whyte, B.S. 

MW3. The Joy Luck Club: Universal Stories About Mothers and Daughters From China Chair: Francis Lu, M.D. 

MW4. Provoked: Combating Domestic Violence Indo-American Psychiatric Association; Chair: Vishal Madaan, M.D., Co-Chair: Surinder Nand, M.D. 

Medical Update (~1.5 hr each) 

MU1. 21st Century ECT—Updating the APA Recommendations on ECT Task Force to Revise the Practice of Electroconvulsive Therapy; Chair: Sarah Lisanby, M.D., Co-Chair: Richard Weiner, M.D. 

Presidential Symposia (~3 hr each) 

PS01. Is Psychiatry Better for Patients and Physicians in a Real Health Care System? Chair: Gisele Apter, M.D., Ph.D. 

PS02. Psychiatrists' Relationships With Industry Chair: Paul Appelbaum, M.D., Co-Chair: Laura Roberts, M.D. 

PS03. Psychiatry and the Control of Fertility Chair: Gail Robinson, M.D., Co-Chair: Susan Kornstein, M.D. 


Scientific and Clinical Reports (~0.5 hr each; ~1.5 hr each session) 

Session 1. Forensic Psychiatry 

1. Characteristics of Mentally Ill Offenders From 100 Psychiatric Court Reports Yasser Elsayed, M.D., M.S. 

2. Homicide and During the First Episode of Psychotic Illness Olav Nielssen, M.B.B.S. 

3. Differences Between Men and Women Found Not Guilty By Reason of Insanity for Homicide Offenses at Napa State Hospital Jessica Ferranti, M.D. 

Session 2. Measurement of Personality Disorder Severity 

4. The Severity Indices of Personality Problems—A New Dimensional Questionnaire for Measuring (mal)Adaptive Personality Functioning Helene Andrea 

5. Severity Indices of Personality Problems (SIPP-118) in Adolescents: Factor Structure and Validity Joost Hutsebaut, Ph.D. 

6. The Severity Indices of Personality Problems (SIPP-118) as a Clinical Instrument Dineke Feenstra, M.A. 

Session 3. Genetic, Neuroimaging, and Neuropsychological Studies in Schizophrenia 

7. Does Aberrant Stimulus Salience Lead to Psychosis in Schizophrenia?: A 20-Year Longitudinal Study Martin Harrow, Ph.D. 

8. Association of G-1438A Polymorphism of 5HT2A Receptor With Schizophrenia in Three Ethnic Groups in Malaysia Zahurin Mohamed, B.S.C., Ph.D. 

9. MEG Analysis of Early Processing of Facial Expressions in Schizophrenia and Controls Stephen Lewis, M.D. 

Session 4. Adjunctive Treatment and Comorbidity in Schizophrenia 

10. Effects of Adjunctive Treatment With Armodafinil in Schizophrenia Ashwin A. Patkar, M.D.

11. Prevalence of Alcohol Use Disorders in Schizophrenia: A Systematic Review and Meta-Analysis Jouko Miettunen, Ph.D. 

12. Zolpidem in Treatment-Resistant Catatonia: Case Reports and Literature Review Cristinel Coconcea, M.D. 

Session 5. Psychopharmacology: Psychostimulant, Antidepressant Side Effects 

13. Linking Attention-Deficit/Hyperactivity Disorder Ratings and Clinical Global Impressions Scores in Studies of Lisdexamfetamine Dimesylate in ADHD Richard Weisler, M.D. 

14. Antidepressant-Induced Excessive Sweating (ADIES): Measurement and Treatment Rajnish Mago, M.D. 

15. Armodafinil Once Daily Sustains Wakefulness Throughout the Day in Patients With Excessive Sleepiness Associated With Narcolepsy Thomas Roth, Ph.D. 

Session 6. Bipolar Disorder 

16. Who Receives Guideline-Based Pharmacotherapy for Bipolar Depression? Megan Ehret, Pharm.D. 

17. Psychiatric Admissions and Hospitalization Costs in Bipolar Disorder in Sweden Anne Tiainen, M.P.H., R.N. 

18. Symptoms and Treatment of Bipolar Disorder in Sweden Mats Adler, M.D. 

Session 7. The Broad Reach of Psychiatry: Studying History, Peacekeeping, and the Role of Spirituality in Schizophrenia 

19. The Modern History of American Psychiatry: Unintended Consequences Milton Kramer, M.D. 

20. Is Peacekeeping Peaceful? A Systematic Review Jitender Sareen, M.D. 

21. Spiritual and Religious Coping in Schizophrenia: Clinical Implications Philippe Huguelet, M.D. 

Session 8. Studies in Psychotherapy 

22. Follow-Up Psychotherapy Outcome of Patients With Dependent, Avoidant, and Obsessive-Compulsive Personality Disorders—a Meta-Analytic Review Witold Simon, M.D., Ph.D. 

23. The Effectiveness of Evidence-Based Treatments for Major Depressive Disorder in a Routine Clinical Setting: Results From an Observational Study Frenk Peeters, M.D., Ph.D. 

24. The Effectiveness of a Group-Oriented Inpatient CBT Program Katherine Lynch, Ph.D. 

Session 09. Child and Adolescent Psychiatry 

25. Medication Trends in New-Onset Pediatric Bipolar Disorder Among Medicaid-Insured Youth Aloysius Ibe, B.S., M.S. 

26. Physical Activity and Fitness in Adolescents at Risk for Psychosis Jenni Koivukangas 

27. Metabolic Symptoms in Adolescent Psychiatric Inpatients Michael Stevens, Ph.D. 

Session 10. Cross-Cultural Psychiatry 

28. Genes, Memes, Migration, and Mental Illness Hoyle Leigh, M.D. 

29. One-Year Follow-Up Study of the Culturally Sensitive Collaborative Treatment (CSCT) for Chinese Americans With Depression Adrienne van Nieuwenhuizen, B.A. 

30. Prevalence of Childhood Trauma in Psychiatric and  Mexico Border Alejandra Postlethwaite, M.D.

Session 11. Diagnostic Issues 

31. Heterogeneity of the Jealousy Phenomenon in the General Population: An Italian Study Donatella Marazziti, M.D. 

32. Olfactory Reference Syndrome (ORS): A Systematic Review of the World Literature Millia Begum, M.B.B.S., M.Eng. 

33. Dimensionality and Etiology in Psychiatric Research Stephen Shanfield, M.D. 

Session 12. Metabolism, Metabolic Syndrome, and Cardiovascular Disease in Schizophrenia 

34. Schizophrenia-Spectrum Disorders Were Associated With Cardiovascular Disease Symptoms, Independent of Known Risk Factors for Symptoms Stephen Woolley, D.Sc., M.P.H. 

35. Ultra Rapid Metabolizers Are in a Pilot Study in Two Different Clinics Over-represented in Court-Ordered Psychotic Patients Carel de Blécourt, M.D., Ph.D. 

36. Oatmeal vs. Donuts: Treating Metabolic Syndrome/Obesity Using CBT/DBT in an Inner-City SPMI Population Joanne Caring, M.D. 

Session 13. Diagnostic Issues in the Schizophrenia Spectrum 

37. Is Schizoaffective Disorder a Distinct Clinical Entity? John Goethe, M.D. 

38. Diagnostic Stability in Patients With Schizoaffective Disorder Compared to Schizophrenia and Bipolar Disorder Bonnie Szarek, R.N. 

39. Depression and Its Treatment in Patients Presenting With Late-Onset Delusional Disorder (LODD) Rebecca Anglin, M.D. 

Session 14. Psychiatric Issues Related to Pregnancy and Breast Feeding 

40. Postpartum Depression and Breast Feeding in an Urban Population of Women in Malaysia Nor Zainal, M.B.B.S., M.Psy. 

41. Psychotic Denial of Pregnancy: Ethical and Legal Considerations for Treating Physicians Melissa Nau, M.D. 

42. Posttraumatic Growth and Quality of Life in Breast Cancer Patients Derya Iren Akbiyik, M.D., Ph.D. 

Session 15. Exploring Suicidality: Assessment and the Impact of Spirituality and Economic Conditions 

43. Meeting the Challenge of Risk Assessment: Toward a New Scale of Suicide Assessment: The Scale for Impact of Suicidality Management and Assessment Amresh K. Shrivastava, M.D., D.P.M. 

44. Economic Factors and Suicide Rates—Associations Over Time in Four Countries Alfonso Ceccherini-Nelli, M.D. 

45. Religion, Spirituality, and Suicide in a Large Community Sample Daniel Rasic, B.S., M.D. 

Session 16. Panic and Anxiety Disorder 

46. Frequency and Clinical Correlates of Adult Separation Anxiety Disorder in 508 Outpatients With Mood and Anxiety Disorders Stefano Pini, M.D. 

47. Long-Term Treatment of Panic Disorder With Clonazepam or Paroxetine: A Randomized, Naturalistic, Open Study Antonio Nardi, M.D., Ph.D. 

48. Effectiveness of a Mindfulness-Based Cognitive Therapy Program as an Adjunct to Pharmacotherapy in Patients With Panic Disorder Borah Kim, M.D. 

Small Interactive Sessions (~1.5 hr each) 

SI01. Safety Issues in Child Psychopharmacology. Barbara Coffey, M.D. 

SI02. Antipsychotic Polypharmacy: An Evidence-Based Perspective. Donald Goff, M.D.

SI03. Psychiatric Issues Related to Returning Vets From Iraq Charles Hoge, M.D. 

SI04. A Discussion and Open Forum About Drug Interactions Gary H. Wynn, M.D. (Meet the Author) 

SI05. Neuropsychiatric Assessment for General Psychiatry Sheldon Benjamin, M.D. 

SI06. Palliative Care and Psychiatric Issues at the End of Life William Breitbart, M.D. 

SI07. When a Physician Is Your Patient Michael Myers, M.D. 

SI08. Approach to the Psychiatric Patient John W. Barnhill, M.D.

SI09. Brain Stimulation Therapies for Clinicians Ned Higgins, M.D. 

Special (1.5 hr)

Opening Session and Presidential Address 

Symposia (~0.5-0.75 hr each; ~3 hr for each session) 

S1. Spotting the Wolf in Sheep's Clothing: Clinical Challenges Identifying and Treating Unpresented Comorbidity National Institute on Drug Abuse 

A. The Prevalence of Substance Use Disorders Among Psychiatric Populations Carlos Blanco-Jerez, M.D. 

B. Screening for Substance Use Disorder Among Individuals With Severe Mental Illness Stanley D. Rosenberg, Ph.D. 

C. Motivational Interviewing for Substance Abuse Among Adolescents With Psychiatric Comorbidity Richard A Brown, Ph.D. 

D. Diagnosis Challenges for Co-Occurring ADHD and Substance Use Disorders Frances Levin, M.D. 

E. The Treatment of Co-Occurring Mood and Anxiety Disorders in Addictions Kathleen Brady, M.D. 

S2. Adjustment Disorders: Problems in Conceptualization, Conundrums in Classification 

A. Adjustment Disorders and DSM-V: Considerations for Dimensional (Spectrum Diagnoses) Versus Categorial James J. Strain, M.D. 

B. Recent Advances in the Study of Adjustment Disorders Andreas Maercker, M.D. 

C. Can Adjustment Disorder and Depressive Episode Be Distinguished? Results From the ODIN Study Patricia P. Casey, M.D. 

D. Posttraumatic Embitterment Disorder Michael Linden, M.D. 

S3. Delivering Psychiatry in Rural Peru: The Ayacucho Mental Health Project 

A. The Ayacucho Mental Health Project James Phillips, M.D. 

B. Constructing a Formulary for a Psychiatric Clinic in the Developing World Mark D. Rego, M.D. 

C. Psychiatric Treatment in a Trilingual Setting Stephen J. Bittner, M.D. 

D. The Use of Skype by the Ayacucho Team in Follow-Up, Supervision, and Other Contacts With Patients and Staff Galen W. Stahle, M.D. 

E. Evaluation of Change in Indicators of Mental Health in an Andean Region of Peru Luis E. Bedregal, Ph.D. 

S4. Stalking: Risk Management and Treatment of Offenders and Victims 

A. A Comprehensive Approach to the Treatment of Stalking Victims Gail E. Robinson, M.D. 

B. Stalking of Health Care Professionals Karen M. Abrams, M.D. 

C. Treatment of Stalking Offenders Werner Tschan, M.D. 

D. Workplace Assessment of Violence Risk Stephen G. White, Ph.D. 

E. Stalking Threat Management Jeffrey Dunn, M.D. 

S5. Understanding and Addressing Adolescent Alcohol Consumption and Alcohol Use Disorders in the Context of Overall Development National Institute on Alcohol Abuse and Alcoholism 

A. Early Development and Continuity of Risk for Early Drinking, Problem Drinking, and Alcoholism From Early Childhood to Adulthood Robert A. Zucker, Ph.D. 

B. Applying a Developmental Framework to Alcohol-Related Behaviors: Ages 10-15 Michael Windle, Ph.D. 

C. Applying a Developmental Framework to Alcohol-Related Behaviors From Middle to Late Adolescence Sandra A. Brown, Ph.D. 

D. Developmentally Informed Research on the Effectiveness of Clinical Trials (DIRECT) With Adolescents With Alcohol Problems Eric F. Wagner, Ph.D. 

E. Evidenced-Based Treatments for Alcohol Use Disorders in Adolescents Deborah Deas, M.D., M.P.H. 

S6. "In or Out?": A Discussion About Gender Identity Diagnoses and the DSM (DSM Track DM03) 

A. The DSM-V Revision Process: Principles and Progress William E. Narrow, M.D. 

B. Beyond Conundrum: Strategies for Diagnostic Harm Reduction Kelley Winters, Ph.D. 

C. Aligning Bodies With Minds: The Case for Medical and Surgical Treatment of Gender Dysphoria Rebecca Allison, M.D. 

D. The Role of Medical and Psychological Discourse in Legal and Policy Advocacy for Transgender Persons in the U.S. Shannon P. Minter, J.D. 

S7. Relationship of Subthreshold Psychiatry to Axis II (Personality Disorders) 

A. Relationship of Subthreshold Psychiatry to Personality Disorders Ahmed Okasha, M.D. 

B. Personality Disorders, Their Thresholds, and Public Health Norman Sartorius, M.D. 

C. Schizophrenia/Schizotaxia: A Genetic Predisposition of Schizophrenia Ming T. Tsuang, M.D. 

D. On the Shared Diathesis of Borderline Personality and Bipolar Hagop S. Akiskal, M.D. 

E. Generalized Anxiety Disorder and Avoidant Personality Disorder Juan J. Lopez-Ibor, M.D. 

S8. Educating a New Generation of Physicians in Psychiatry: Reports From Winners of APA Innovative Teaching Grants APA Corresponding Committee on Medical Student Education 

A. Changing Perspectives: Reducing the Stigma of Mental Illness in Medical Students Through the Living Museum Project Janis Cutler, M.D. 

B. A School-Based Medical Student Curriculum for Education in Child and Adolescent Psychiatry Justine Larson, M.D. 

C. Teaching Third-Year Medical Students Brief Motivational Interviewing Skills to Use in Counseling Patients With Mental Illness on Smoking Cessation Brenda J.B. Roman, M.D. 

D. Preventing and Managing Metabolic Syndrome Among the Seriously Mentally Ill: Teaching Behavioral Medicine to Medical Students Jason B. Rosenstock, M.D. 

S9. Effective Assessment and Treatment of Sexual Dysfunction in Adults and the Elderly 

A. Clinical Presentation and Assessment of Sexual Dysfunction in Patients With Psychiatric Illness Jeffrey D. Raynor, M.D. 

B. Treatment of Psychotropic-Induced Sexual Dysfunction Travis O. Bruce, M.D. 

C. Sexual Dysfunction in Late Life: Beyond "Vitamin V" Shilpa Srinivasan, M.D. 

S10. The Neurobiological Evidence for Transgenderism 

A. Brain Gender Identity Sidney W. Ecker, M.D. 

B. Transsexuality as an Intersex Condition Milton Diamond, Ph.D. 

C. Novel Approaches to Endocrine Treatment of Transgender Adolescents and Adults Norman Spack, M.D. 

S11. Comprehensive HIV Psychiatry Update 

A. HIV/AIDS Medical Update Paul Volberding, M.D. 

B. Neuropsychiatric Overview of HIV/AIDS Robert Daroff Jr., M.D. 

C. Neurocognitive Decline Karl Goodkin, M.D. 

D. Psychopharmacology Gabrielle Marzani-Nissen, M.D. 

S12. The OC Spectrum in the Athlete: Psychopathology or Competitive Edge? International Society for Sport Psychiatry 

A. An International-Level Athlete's Struggle With Obsessive-Compulsive Disorder David O. Conant-Norville, M.D. 

B. Athletes and Superstition Thomas S. Newmark, M.D. 

C. The OC Spectrum in the Athlete: Psychopathology or Competitive Edge Saul I. Marks, M.D. 

S14. Increasing the Likelihood of Achieving Remission in Depression 

A. Medication Algorithms for Antidepressant Treatment: Lessons Learned From STAR*D and Other Practical Clinical Trials Madhukar H. Trivedi, M.D. 

B. Strategies for Medication Management of Treatment Resistance: Lessons From STAR*D Maurizio Fava, M.D. 

C. Use of EEG Biomarkers to Direct Selection of Antidepressant Medication Andrew F. Leuchter, M.D. 

D. Collaborative Care Approaches to Depression Jurgen Unutzer, M.D. 

E. Can Genetic Biomarkers Help Direct Treatment for Depression? Gonzalo Laje, M.D. 

S15. The Transmission of Borderline Personality Disorder 

A. The Aggregation of DIB-R and DSM-IV Borderline Personality Disorder Mary C. Zanarini, Ed.D. 

B. Familial Coaggregation of BPD With Axis I Disorders James I. Hudson, M.D. 

C. Familial Aggregation of Attachment in Borderline Personality Disorder Lois W. Choi-Kain, M.D. 

D. Familiality of BPD's Component Phenotypes John G. Gunderson, M.D. 

E. An Endophenotypic Approach to Borderline Personality Disorder Larry J. Siever, M.D. 

S16. Contributions of Neuroscience to Medications Development for Alcohol Use Disorder. National Institute on Alcohol Abuse and Alcoholism 

A. Novel Targets From the Dark Side of Dependence on Alcohol: Focus on CRF, Norepinephrine, and Vasopressin George F. Koob, Ph.D. 

B. Activation of the Nociceptin/Orphanin FQ System Reduces Alcohol Abuse–Related Behaviors in Rats With Innate Predisposition to Excessive Alcohol Intake and Elevated Anxiety Roberto R.C. Ciccocioppo, Ph.D. 

C. N-Type Calcium Channel Blockers for Alcohol Use Disorders: From Cells to People Robert O. Messing, M.D. 

D. New Array of Potential Treatments for Alcohol Use Disorders: From Drosophila to Electophysiology and More Predictive Animal Models Selena E. Bartlett, Pharm.D. 

E. The Emerging Role of Pharmacogenetics in Medications Development for Alcoholism: the Case of the Mu-Opioid Receptor Vijay A. Ramchandani, Ph.D. 

S17. Monitoring Equity in Mental Health From a Cross-National Perspective 

A. Equity in Determinants of Health and Health Policies Influencing Mental Health: A Cross-National Perspective Donna Stewart, M.D. 

B. Monitoring Equity in Mental Health in Lower-, Middle-, and High-Income Countries Natalia Diaz-Granados, M.S.C. 

C. Sociodemographic Factors Affect Mental Illness Rates Differently Across Countries Marta B. Rondon, M.D. 

D. Factors Associated With Inequities in Mental Health Care Use in a Developing Country Javier E. Saavedra, M.D. 

E. Income-Related Inequity in Mental Health Service Utilization in Colombia and Canada Marie DesMeules, M.S.C. 

S18. Recovery and Rehabilitation: From the Provider and Patient Points of View in France and the U.S.: Vive la Difference! 

A. Recovery From Disability of Serious Mental Disorders: A Phase-Linked Rehabilitation Process Robert P. Liberman, M.D. 

B. Can We Implement Recovery and Rehabilitation?: What Do We Know and What Are the Implications for Services? Marianne D. Farkas, Sc.D. 

C. An Individualized Cognitive Remediation Therapy for Patients With Schizophrenia: The RECOS Program Pascal Vianin, Ph.D. 

D. Functional Remission in Schizophrenia: A Specific Tool for Evaluation Pierre Michel Llorca, M.D.   

S19. Suicide Without a Psychiatric Disorder 

A. Had Gary Powers Killed Himself Norman B. Levy, M.D. 

B. Differentiating Suicide From Other Life-Ending Acts: A Model Illustrated With Chronic Kidney Disease and Dialysis John M. Bostwick, M.D. 

C. Oregon's Death With Dignity Act: Who Chooses Physician-Assisted Suicide Linda Ganzini, M.D. 

D. Desire for Death in Terminally Ill Cancer and AIDS Patients: Hopelessness and Loss of Meaning as Contributing Factors, Independent of Depression William Breitbart, M.D. 

E. Ethics in Suicide That Is Not Associated With Psychiatric Illness James J. Strain, M.D. 

S20. Biological Basis of Sex Differences in Drug Addiction: Translational Perspectives National Institute on Drug Abuse 

A. Sex Differences in Biological Sensitivity to the Reinforcing Effects of Drugs of Abuse in Preclinical Models of Acquisition, Escalation, and Relapse Wendy J. Lynch, Ph.D. 

B. The Role of Dopamine in Sex Differences in Drug Abuse Jill B. Becker, Ph.D. 

C. Gonadal Steroid Hormones and Neural Mechanisms of Cognition and Emotion in Women Karen Faith Berman, M.D. 

D. Sex Differences in fMRI Correlates of Stress and Drug Cues in Cocaine Dependence Marc N. Potenza, M.D. 

E. Sex Differences in Amygdala-Based Emotional Memory Processes: Relevance for Addiction Larry F. Cahill, Ph.D. 

S21. Co-occurring Disorders in HIV Positive Patients 

A. HIV and Hepatitis C Co-Infection Elizabeth Ryan, M.D. 

B. Metabolic Disease and HIV Marshall Forstein, M.D. 

C. PTSD and HIV Antoine Douaihy, M.D. 

D. Update on Severe Mental Illness and HIV Francine Cournos, M.D. 

E. Substance Use Disorders and HIV Steven Batki, M.D. 

S22. Starting Out on the Right Foot: Securing Your First Job and Establishing a Psychiatric Practice APA Committee of Residents and Fellows 

S23. Social Stress Increases Vulnerability to Drug Abuse and Disease National Institute on Drug Abuse 

A. Adverse Effects of Stress on Drug Addiction Julie Blendy, Ph.D. 

B. Social Stress and Vulnerability to Substance Abuse: Genes, Environment, and Neural Correlates Huda Akil, Ph.D. 

C. Interactions of Social Stressors and Enrichment With Social Rank on Dopamine D2 Receptors and the Reinforcing Strength of Cocaine in Monkeys Michael A. Nader, Ph.D. 

D. Social Stress and Simian Immunodeficiency Virus Disease: Behavioral and Physiological Mechanisms That Affect Disease Progression John P. Capitanio, Ph.D. 

S24. What's New in Pharmacotherapy for Alcohol Dependence? National Institute on Alcohol Abuse and Alcoholism 

A. Neurokinin 1 Receptor (NK1R) Antagonism: A Novel Anti-Stress Mechanism for the Treatment of Alcoholism David Ted George, M.D. 

B. Human Laboratory and Clinical Trial Evidence for Gabapentin Treatment of Alcohol Dependence Barbara J. Mason, Ph.D. 

C. Update on New Clinical Trials for Alcohol Dependence: Opiate, Dopamine, and GABA/Glutamate Acting Medications Raymond F. Anton, M.D. 

D. An Analysis of Two Promising Medications, Topiramate and Ondansetron, for Treating Alcohol Dependence: Results From Recent Large-Scale Clinical Trials Bankole A. Johnson, D.Sc. 

E. Pharmacogenetics and Alcohol Dependence Henry R. Kranzler, M.A. 

S25. Autism in Adults—Toward a Better Clinical Approach Through Understanding: Recent Insights From Research 

A. Neurodevelopmental Correlates of Social Impairment in Autism: From Infancy to Adulthood Ami Klin, Ph.D. 

B. Diffusion Tensor Imaging in Autism and Asperger Syndrome: Evidence for Impairment of Long Range White Matter Integrity Wouter Groen, M.D. 

C. Neurocognitive Correlates of Substance Use Disorder in Adults With Autism Spectrum Disorder or ADHD Bram B. Sizoo, M.D. 

D. Comorbidity in Adults With ASD: Evidence From Data From Cross-Sectional and Prospective Case-Controlled Cohort Samples Patricia J. van Wijngaarden-Cremers, M.D. 

E. ASD in Parents and Siblings of Early Diagnosed Infants With ASD Rutger J. Van der Gaag, M.D. 

S26. The Effects of City Life on Mental Health Around the World Royal College of Psychiatrists 

A. The Impact of Urban Living on Mental Health and Illness in Egypt Nasser N. Loza, M.D. 

B. Mental Disorders and Quality of Life in Large Metropolitan Areas in Mexico Maria E. Medina Mora, Psy.D. 

C. Metro-Urban Mental Health in Developing Countries: From Origins to Outcome: An Indian Experience Amresh K.A. Shrivastava, M.D. 

D. A Population-Based Study of First Episode Psychosis in São Paulo, Brazil Paulo Menezes, M.D. 

E. Chinese Elderly in Singapore: Comparing the Mental Health of an Urban and a Suburban Population Ee-Heok Ehk Kua, M.B.B.S. 

F. The Practice of Mental Health Promotion in Urban Planning and City Administration Helen E. Herrman, M.B. 

S27. Recent Research in Eating Disorders 

A. Psychopathology and Eating Pathology in Bariatric Surgery Candidates James E. Mitchell, M.D. 

B. Disordered Eating and Psychiatric Symptoms in Adolescents Presenting for Bariatric Surgery Michael J. Devlin, M.D. 

C. Recent Mortality Studies in Eating Disorders Scott J. Crow, M.D. 

D. A Model of Allostasis for Conceptualizing Eating Disorders Katherine A. Halmi, M.D. 

E. Are Anorexia Nervosa and Bulimia Nervosa Really Eating Disorders: New Understanding of Puzzling Symptoms Walter H. Kaye, M.D. 

S28. Publication Bias and the Effectiveness of Antidepressant Treatment and Psychological Interventions in Depression: Should We Care? 

A. Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy Erick H. Turner, M.D. 

B. Publication Bias Is Not Restricted to Reporting Outcomes of Pharmacotherapy Trials Willem W.A. Nolen, M.D. 

C. Nonresponse to CBT and Antidepressants in the Treatment of Depression in Myocardial Infarction Patients Elisabeth Martens, M.D. 

D. How Well Do We Treat MDD? Claudi C.L.H. Bockting, Ph.D. 

S29. Borderline Personality Disorder: The Role of Neurobiology and Genes 

A. Opioid Receptor and Oxytocin Genotypes in BPD Larry J. Siever, M.D. 

B. Dysregulation of Endogenous Opioid System Function in Borderline Personality Disorder Jon-Kar Zubieta, M.D. 

C. Pain Processing in Borderline Personality Disorder: Functional and Genetic Approach Martin Bohus 

D. Neurobiology of Self-Injury in Borderline Personality Disorder Barbara H. Stanley, Ph.D. 

S30. Current and Future of the Emergent Field of Therapeutic Brain Stimulation and Neuromodulation in Psychiatry 

A. Neurosurgery for OCD: Focus on Deep Brain Stimulation Benjamin D. Greenberg, M.D. 

B. Feasibility Study of an Implantable Cortical Stimulation System for Patients With Major Depressive Disorder Darin D. Dougherty, M.D. 

C. Deep Transcranial Magnetic Stimulation: Comparison Between Effects of Unilateral and Bilateral Prefrontal Cortex Stimulation in Depressive Patients Abraham Zangen, Ph.D. 

D. Current and Future Therapeutic Uses of rTMS Mark S. George, M.D. E. Current and Future of Other Brain-Stimulating Techniques Alexander Bystritsky, M.D. 

S31. Pediatric Bipolar Disorder: A Critical Look at an American Phenomenon 

A. Australian and New Zealand Child and Adolescent Psychiatrists' Views on Bipolar Disorder Prevalence and on Rates of Pediatric Bipolar Disorder in the USA Peter I. Parry, M.B.B.S. 

B. Changing the Treatment Culture in a Residential Agency for Youth: Broadening the Role of Psychiatry Edmund C. Levin, M.D. 

C. Pediatric Bipolar Disorder: A Dispassionate Review of the Literature Glen R. Elliott, M.D.  

D. Bioethics and "Pediatric Bipolar Disorder" Mary G. Burke, M.D. 

S32. Working With Lawyers 

A. Values of Medicine and the Law Roger Peele, M.D. 

B. Brownlee v. Me: A Good Lawyer Directs the Process and Gets a Favorable Summary Judgment Lawrence K. Richards, M.D. 

C. New Opportunities for Attorney/Psychiatrist Collaborations Bruce J. Winick 

D. Beyond "Get the Money Up Front" Thomas G. Gutheil, M.D. 

E. Working With Lawyers Harold I. Eist, M.D. 

S33. Empirically Validated and Effective Psychotherapies for Borderline Personality Disorder 

A. Evidence-Based Versus Effectiveness Studies: The Randomized, Controlled Trial and Psychotherapy Research Kenneth R. Silk, M.D. 

B. Mentalization Based Treatment: A Discussion of Theory and Evidence Anthony W. Bateman, M.R.C. 

C. Transference-Focused Psychotherapy for BPD: Aiming for Change in Personality Structure Frank E. Yeomans, M.D. 

D. Dialectical Behavior Therapy for Complex, Multi-Diagnostic Patients—A Review of DBT's Evidence Base to Date Linda A. Dimeff, Ph.D. 

E. CBT for Personality Disorders (CBT-PD) Kate M. Davidson, Ph.D. 

F. Schema Therapy for Borderline Personality Disorder Jeffrey E. Young, Ph.D. 

S34. Advances in Neuropsychiatry and Clinical Neurosciences 

A. Windows to the Brain: Clinical and Functional Imaging in Psychiatry Robin A. Hurley, M.D. 

B. Current Controversies and Research Oportunities in the Neuropsychiatric Aspects of Delirium Paula Trzepacz, M.D. 

C. Neuropsychiatry of Traumatic Brain Injury Jonathan Silver, M.D. 

D. Advances in Neuropsychiatric Disorders Associated With Cerebrovascular Disease Robert G. Robinson, M.D. 

S35. PTSD and Alcohol Use Disorder (With Special Emphasis on Returning Veterans) National Institute on Alcohol Abuse and Alcoholism 

A. Psychotherapy Treatments for PTSD and Alcohol Use Disorder Lisa M. Najavits, Ph.D. 

B. Neurobiological Determinants of the Comorbidity of PTSD and Substance Abuse Thomas R. Kosten, M.D. 

C. Pharmacotherapeutic Treatment of PTSD and Co-Occurring Alcohol Use Disorders Kathleen Brady, M.D. 

D. Outcomes for Alcohol-Misusing Women With PTSD in the Women and Trauma Multisite Study in NIDA's Clinical Trials Network Denise Hien, Ph.D. 

E. Impact of Childhood Trauma on Hypothalamic-Pituitary-Adrenocorticol (HPA) Activity in Alcohol-Dependent Patients Ingo Schäfer, M.D. 

S36. Psychiatric Patients' Overcrowding in Emergency Departments: A Call for Actions APA 

Council on Healthcare Systems and Financing 

A. Overview of Psychiatric Patient Overcrowding in Emergency Departments Scott L. Zeller, M.D. 

B. Health Care Delivery System Influences and Impacts—Strategies for Improvement Joseph J. Parks, M.D. 

C. Innovative Methods to Decrease Psychiatric Patient Overcrowding of Medical Emergency Departments Avrim B. Fishkind, M.D. 

D. Behavioral Health Service Gaps and the Role of Emergency Departments Alan Q. Radke, M.D. 


Anonymous said...

In the past the APA used to sell mail order tape recordings, then later audio CDs of the sessions.
Better than online access these recordings could be passed from one person to the next.

Will they no longer be sold?

Roy said...

I should clarify that this is just for brain-storming, not official policy or anything. I'm not speaking for the APA, but am trying to do some idea generation.

I have no reason to think that the CDs would not still be sold. One of the advantages to online is that you see the slides that the speaker is referring to.

Owner said...

Great post Roy, I think this is really relevant. I would support paying for the talks, but I wouldn't be happy with paying and then not having the option to download.

Zoe Brain said...

S6 and S10 - I'd pay $25 a year to stream them, or rather more to download.

With the author's permission, I'm mirroring the slides for one of the talks in S10, and an extensive list of references. I've been in contact with Dr Ecker, and other researchers in the area.

The evidence for a neuroanatomical cause for transsexuality is just plain being ignored by the sexual disorders group, in favour of neo-freudian theory.

I expect a huge to-do, and outright rejection of the recommendations, if they remain as stated in the recent STARS conference.

The initial proposals pathologise, inter alia, masturbation, and any sexual activity not resulting in, or expected to result in, intercourse. As well as any attraction to anyone not "phenotypically normal" - too thin, too fat, transsexual, amputee etc.

It appears that "somatically normal" means of either sex, and intercourse can be anal. But attraction to anyone disfigured, transsexual, phenotypically intersexed, disabled etc or any sexual behaviour not leading to intercourse is pathologised.

All such cases will be assessed as paraphiliac, and if distress is caused then the patient will be diagnosed with a paraphillic disorder.

Well, I always thought any guy would have to be crazy to be attracted to a woman like me, but to have any such attraction to be diagnosed (or assessed) as paraphilliac by its very nature is going a little far.

Transgendered people have had misgivings (to say the least) about the composition of the sexual disorders group, with CAMH and Conservative Catholicism between them providing the largest single bloc. Hence the demonstrations outside, with promininent MDs speaking. But no-one expected anything quite so extreme, even from them.

Anonymous said...

This is the world's longest blog post.

Anonymous said...

As someone not in psychiatry, I'll say that I might be interested in some of these talks but that it's hard to tell from the titles which ones I would actually appreciate and which (from my perspective) would turn out to be duds, e.g. too narrow or too technical to be of use. So from that point of view, even $8/talk is too much. And to be honest, if I was sure if I wanted to see & hear a talk, why would I need access to it for a year? I can take notes.

Of more interest would be a browsing model, i.e. access to a set of talks (possibly of my choosing) for a price, for a period of time. Kind of like a grab bag.

So what happens after a year? That's the sell-by date and everything is free? (Some of it will be in print by then, of course.)

Roy said...

Long post: yeah, I thought about linking to the course list, but it is a 2MB pdf and not as easily scanned by eye.

Karla: I'm thinking downloads will get reposted on blogs and emailed around too much, thus the long access to watch again. What do you think?

what happens in a year: well, the NEXT annual meeting. Since it is streaming, I thought ongoing access until the next set came out made sense. Maybe it should just be until the next meeting, rather than "1 year". If it is just one time (ie, 1 viewing), than you'd have to pay again if you missed something, so some time period makes sense. I guess it could be shorter.

The problem with the grab bag approach is the price might be too much--it will not be cheap to professionally record all 600 talks (or even a portion of them), and then manage the website and bandwidth costs. I guess if it were, say, 24 hrs access, a charge of maybe $99 might work (ie, how many will one watch in a day?).

I was thinking more about a way for folks who HAD purchased and viewed to write reviews (think iTunes) or to comment or discuss (think YouTube) about the specific talk. Maybe there could be like 30-second excerpts that could be watched. Finally, I'm pretty sure that each talk has an abstract written by the author(s), so the abstract could be linked to.

Also keep in mind that it would have to priced such that member access is significantly cheaper but still does not lose money (maybe a one price for all deal for members?) -- after all, the main reason for the meeting is for APA member education/benefit. It might be that an appropriate nonmember price would simply not be attractive, but I'm thinking that such a treasure chest of gems (and duds!) is too good to just hoard for members only.

I appreciate the brainstorming on this. Other thoughts?

Retriever said...

Put them on ITunes or set up another site independently of Apple and share it for free. That's the best use of the Internet. There is so much bilge on mental health that they have on Itunes right now (a few select exceptions, obviously).

In fact. here is another radical suggestion: abolish the system of forcing people to pay $15 or whatever for a day's access to decent clinical research pieces on line. It smacks of guild secrecy and is totally unnecessary. Researchers get grants to do the research, so why charge tolls for people reading their work? Don't they want to share their findings with a wider audience?

Imagine Open Course Ware for psychiatric and psychological research as MIT and Cambridge University and others are already doing. Wouldn't it be better to publicize decent research than leave people to read the drivel in popular magazines or dumbed down AOL articles???

My library never stocked any books or research articles on the conditions my son has variously been diagnosed with so the only time I could study the literature was once when a sympathetic resident at the hospital let me use their library (while kid was there), or else ordering interlibrary loan books which can take weeks to arrive. Obviously I bought a lot initially mail order, but stuff gets outdated so quickly.

Roy said...

Retriever-While I understand where you are coming from, I don't see how that model would be sustainable (free). It would cost a fair bit to record, edit, & produce the video of the talk. How else would that be paid for. Additionally, the economy is hitting the APA hard (like every one else) at the same time that the tide is turning against pharmaceutical company sponsorship, so new sources of revenue need to be developed. Also, if it was given away for free, then attendance at meetings would go way down, there'd be nobody to give the talk to, and that would be that. I don't think people would be very motivated to give a talk just to a camera. Finally, most of these talks (except for maybe the poster sessions and some of the research sessions) are not paid for by research money but are reviews of topic areas, rather than a single research study.

Helen Schultz said...

Hi there,
I ventured over to the APA from Australia and really enjoyed the content, but was disappointed about the lack of materials included in the price; I enrolled for 2 fullday workshops at the cost of $400 US dollars on top of my non APA member fee. It was also very disappointing to not have a blank notepad let alone a synopsis of slides for the main lectures. I obtained my CD ROM but wouldn;t want much more; I think some of these materials should have been included in the price. On another note, Maureen McCormick was enlightening and to see Irvin Yalom was truly a career highlight.

nardilfan said...

Wow, the doc who prescribed me phenelzine is one of the doctors on that list, giving a presentation! Cooool. Supercool. I've been trated by a celebrity!


nardilfan said...

Treated. Grrr.